Characterisation of DNA methylation changes in EBF3 and TBC1D16 associated with tumour progression and metastasis in multiple cancer types

Overview of attention for article published in Clinical Epigenetics, August 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 5 news outlets

twitter: 4 X users

Readers on

mendeley: 26 Mendeley

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 904 followers.

RT @ingentium_mel: Characterisation of DNA methylation changes in EBF3 and TBC1D16 associated with tumour progression and metastasis in mul…

Characterisation of DNA methylation changes in EBF3 and TBC1D16 associated with tumour progression and metastasis in multiple #cancer types. https://t.co/PjWEkwe3xM

RT @futureliesindna: Our new paper showing abberant DNA methylation of EBF3 and TBC1D16 in multiple cancer types and its associated with me…

Our new paper showing abberant DNA methylation of EBF3 and TBC1D16 in multiple cancer types and its associated with metastasis. We previously discovered EBF3 as a epigenetic driver of melanoma metastasis. @euanjrodger thanks for driving this @OAgenetics…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.